2024-11-01 | Sale | Madrigal Pharmaceuticals, Inc. MDGL | director | | $300.94 | $1.5M | +3.67% | |
2024-04-01 | Sale | Madrigal Pharmaceuticals, Inc. MDGL | director | | $257.49 | $2.83M | -7.54% | |
2023-01-17 | Sale | Madrigal Pharmaceuticals, Inc. MDGL | director | | $293.15 | $6.59M | -21.53% | |
2020-03-20 | Purchase | Kodiak Sciences Inc. KOD | director | | $44.33 | $88,660 | +40.96% | |
2017-08-23 | Purchase | Madrigal Pharmaceuticals, Inc. MDGL | director | | $16.12 | $32,236 | +580.11% | |
2017-08-22 | Purchase | Madrigal Pharmaceuticals, Inc. MDGL | director | | $16.12 | $57,209 | +613.24% | |
2017-08-21 | Purchase | Madrigal Pharmaceuticals, Inc. MDGL | director | | $15.88 | $56,358 | +614.47% | |
2016-01-06 | Sale | Incyte Corporation INCY | EVP, Chief Drug Dev Officer | | $60.09 | $473,149 | -20.19% | |
2015-12-07 | Sale | Incyte Corporation INCY | EVP, Chief Drug Dev Officer | | $62.25 | $490,157 | -24.24% | |
2015-11-06 | Sale | Incyte Corporation INCY | EVP, Chief Drug Dev Officer | | $67.42 | $530,691 | -18.61% | |
2015-10-06 | Sale | Incyte Corporation INCY | EVP, Chief Drug Dev Officer | | $70.31 | $553,582 | -27.43% | |
2015-09-11 | Sale | Incyte Corporation INCY | EVP, Chief Drug Dev Officer | | $130.00 | $1.12M | -37.51% | |
2015-09-08 | Sale | Incyte Corporation INCY | EVP, Chief Drug Dev Officer | | $68.61 | $540,235 | -31.76% | |
2015-08-06 | Sale | Incyte Corporation INCY | EVP, Chief Drug Dev Officer | | $65.14 | $512,743 | -18.46% | |
2015-07-15 | Sale | Incyte Corporation INCY | EVP, Chief Drug Dev Officer | | $68.89 | $9.68M | -26.04% | |
2015-07-06 | Sale | Incyte Corporation INCY | EVP, Chief Drug Dev Officer | | $62.66 | $493,385 | -10.32% | |
2015-06-19 | Sale | Incyte Corporation INCY | EVP, Chief Drug Dev Officer | | $62.96 | $2.52M | -3.74% | |
2015-06-08 | Sale | Incyte Corporation INCY | EVP, Chief Drug Dev Officer | | $62.95 | $495,668 | -2.61% | |
2015-05-06 | Sale | Incyte Corporation INCY | EVP, Chief Drug Dev Officer | | $58.88 | $872,763 | +5.34% | |
2015-04-06 | Sale | Incyte Corporation INCY | EVP, Chief Drug Dev Officer | | $53.55 | $2.68M | +20% | |